Drug Cartels News | Drug Cartels News – Drug Cartels Information

Pharmaceutical companies

04/09/2018 / By Ethan Huff

Harvard analysis determines: Doctors who prescribe opioids receive HUGE kickbacks from pharma corporations

The opioid epidemic seems to be on everyone’s minds these days, with the Trump administration having recently declared it to be a major “public health emergency,” and one supposedly caused by “drug traffickers” – for which President Trump himself wants to see harsher penalties against “dealers.” But a recent study out of Harvard University reveals […]

01/24/2018 / By David Williams

Manufacturing your own drugs in your own home could soon be possible thanks to 3D printing

3D printing has come quite a long way since experts first started experimenting with it back in the 1980s. These days, it plays a huge role in the intersection of design, manufacturing, and prototyping for consumer products that would otherwise be stuck in industrial limbo, thanks to all of the necessary prerequisites. Even in business […]

11/11/2017 / By Isabelle Z.

Disease outbreaks are often staged to generate funding for Big Pharma

When you have a product to sell, you need to strike the right balance between supply and demand. The basic laws of economics state that when you have a supply of products that you’d like to move, one way to sell them is to create a demand for them. If you’re selling scarves, for example, […]

10/12/2017 / By Isabelle Z.

New Jersey lawsuit accuses Big Pharma of “nothing short of EVIL”

A new lawsuit that accuses a pharmaceutical company of conduct that is “nothing short of evil” echoes the sentiment of many people who have suffered or lost loved ones due to the unsavory practices of Big Pharma. Big Pharma’s list of wrongdoings is rather lengthy, but the offense that is at the heart of the […]

08/22/2017 / By Jhoanna Robinson

Big Pharma is actively blocking efforts to halt the opioid epidemic… because there’s profit in POISON

Robin Feldman, a professor in pharmaceutical law at University of California, testified in September 2016 before the House of Representatives judiciary subcommittee about the state of the opioid addiction in the United States, saying that even though “open and vigorous competition is the backbone of U.S. markets…we are not seeing that in the market for […]

1 of 1